2. Gene
  3. C2 - complement C2 Gene

C2 - complement C2 Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as CO2; ARMD14

Gene ID: 717 | Gene type: protein coding

About C2

Cytogenetic location: 6p21.33 Genomic coordinates (GRCh38): 6:31,897,783-31,945,672 (from NCBI)

This gene has 24 transcripts (splice variants), 1 gene allele, 85 orthologues, 39 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 95.8), lung (RPKM 36.7) and 11 other tissues.

Summary

Component C2 is a serum glycoprotein that functions as part of the classical pathway of the Complement System. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]

C2 Products(6)

mRNA Protein Name
NM_000063.6 NP_000054.2 complement C2 isoform 1 preproprotein
NM_001145903.3 NP_001139375.1 complement C2 isoform 2 precursor
NM_001178063.3 NP_001171534.1 complement C2 isoform 3
NM_001282457.2 NP_001269386.1 complement C2 isoform 4
NM_001282458.2 NP_001269387.1 complement C2 isoform 5
NM_001282459.2 NP_001269388.1 complement C2 isoform 6 precursor

C2 Protein Structure

Sushi

Sushi: Sushi repeat (SCR repeat) (89 - 144)

Sushi

Sushi: Sushi repeat (SCR repeat) (151 - 204)

VWA

VWA: von Willebrand factor type A domain (254 - 452)

Trypsin

Trypsin: Trypsin (473 - 703)

  • 0
  • 200
  • 400
  • 600
  • 752 a.a.
Protein Preferred Names Protein Names

complement C2

C3/C5 convertase

Recombinant C2 Proteins

Cat. No. Product Name Accession Purity
HY-P74375 C2/Complement C2 Protein, Human (HEK293, His) P06681 (A21-L752) ≥95%
HY-P74376 C2/Complement C2 Protein, Human (HEK293, Fc) P06681 (A21-L752) ≥95%

Related Diseases

Diseases Alias
Complement Component 2 Deficiency

C2D

C2 Deficiency

Complement 2 Deficiency

Complement Component-2
Macular Degeneration, Age-Related, 14

Age Related Macular Degeneration 14

ARMD14

Macular Degeneration, Age-Related, 14, Reduced Risk Of

Macular Degeneration, Age-Related, Type 14
Immunodeficiency Due To A Classical Component Pathway Complement Deficiency

Immunodeficiency Due To C1, C4, Or C2 Component Complement Deficiency

Immunodeficiency Due To An Early Component Of Complement Deficiency
Retinal Drusen
Eye Disease

Eye Diseases

Abnormality Of The Eye

Toxoplasma Oculopathy
Lupus Erythematosus

Lupus

Lupus Vulgaris

Lupus Erythematosus, Discoid

Lupus Erythematosus, Systemic

Subacute Cutaneous Lupus

Le - [Lupus Erythematosus]
Macular Degeneration, Age-Related, 1

Macular Degeneration

Age-Related Macular Degeneration

Macular Degeneration, Age-Related

Age Related Macular Degeneration

Age Related Macular Degeneration 1

ARMD1

Senile Macular Degeneration

Maculopathy, Age-Related, 1

Macular Degeneration, Age-Related, Reduced Risk Of

Age Related Maculopathy 1

Age Related Maculopathies

Age Related Maculopathy

Senile Macular Retinal Degeneration

Macular Degeneration Of Retina

Age-Related Maculopathy

Amd

Armd

Age-Related Maculopathy, Susceptibility To

Maculopathy Age-Related

Macular Degeneration, Age-Related, 1, Susceptibility To

Maculopathy, Age-Related

Macular Degeneration, Age-Related, Type 1

Macular Degeneration, Age-Related, 2
Systemic Lupus Erythematosus

Lupus Nephritis

SLE

Disseminated Lupus Erythematosus

Systemic Lupus Erythematosus, Susceptibility To

Lupus Erythematosus, Systemic

Lupus Nephritis, Susceptibility To

Libman-Sacks Disease

Systemic Lupus Erythematosus Susceptibility To

Sle - Lupus Erythematosus, Systemic

Le Syndrome

Lupus

Lupus Erythematosus Systemic

Lupus Erythematosus, Systemic, Susceptibility To

Lupus Vulgaris

Lupus Erythematosus, Discoid

Lupus Erythematosus

Systemic Lupus Erythematosus Nos

Sle - [Systemic Lupus Erythematosus]
Degeneration Of Macula And Posterior Pole

Degeneration Of Macula And Posterior Pole Of Retina

Degeneration Of Macula Or Posterior Pole

Macular Degeneration Nos

Degenerative Disorder Of Macula

Drusen Macular Degeneration

Posterior Pole Macular Degeneration Of Eye

Macular Eye Degeneration

Macular Degeneration Of Retina, Unspecified

Pseudohole Degeneration Of Macula Of Retina
Hemolytic Uremic Syndrome, Atypical 1

Atypical Hemolytic-Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1

Atypical Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome, Atypical, Susceptibility To

Ahus

AHUS1

Hemolytic-Uremic Syndrome

Ahus 1

Ahus, Susceptibility To, 1

Hemolytic Uremic Syndrome, Atypical

Non-Shiga-Like Toxin-Associated Hus

Non-Stx-Hus

Nonenteropathic Hus

Atypical Hus

Shiga Toxin-Associated Hemolytic Uremic Syndrome

D+ Hus

Ehec-Hus

Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli

Hemolytic Uremic Syndrome With Diarrhea

Stec-Hus

Shiga-Like Toxin-Associated Hus

Stx-Hus

Typical Hus

Typical Hemolytic Uremic Syndrome

Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies

Atypical Hus With Anti-Factor H Antibodies

Ahus With Anti-Factor H Antibodies

Ahus With Neutralizing Autoantibodies Against Factor H

Hemolytic Uremic Syndrome Atypical 1

Atypical Hemolytic Uremic Syndrome With H Factor Anomaly

D Hus

Hemolytic-Uremic Syndrome Without Diarrhea

Hemolytic-Uremic Syndrome, Atypical, Type 1

Hemolytic Uremic Syndrome, Typical
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Approval
Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B1915 Micronomicin 95.16% Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99050 Sutimlimab Inhibitor 95.00% Unkown
Clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-113071R Mevalonic acid (Standard) / Phase 3
HY-113697 Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 99.77% Phase 1
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P990091 Riliprubart Inhibitor 99.90% Phase 3
HY-P99163 Tilavonemab Inhibitor 96.22% Phase 2
Pre-clinical Phase
Bioactive Molecules (576)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0155 Nobiletin 99.52% Unkown
HY-113071A Mevalonic acid lithium salt ≥98.0% Unkown
HY-40171 NH2-C2-NH-Boc 99.97% Unkown
HY-W021401 Amino-PEG3-C2-Azido 99.67% Unkown
HY-N0379 D-Mannose ≥98.0% Yes
HY-N0376 Liquiritin 99.68% Unkown
HY-130109 N3-PEG4-C2-NHS ester 98.94% Unkown
HY-100594 EUK-134 98.43% Unkown
HY-42776 NH2-PEG3-C2-NH-Boc 99.34% Unkown
HY-W008474 Boc-NH-PEG2-C2-NH2 99.01% Unkown
HY-101180 C2 Ceramide 99.85% Unkown
HY-140213 Azido-PEG2-C2-amine ≥97.0% Unkown
HY-122502 Pyrazofurin Inhibitor ≥98.0% Unkown
HY-128834 N3-PEG4-C2-NH2 ≥98.0% Unkown
HY-130653 Azido-PEG4-C2-acid ≥98.0% Unkown
HY-42149 NH2-PEG2-C2-Boc ≥98.0% Unkown
HY-137320 diABZI-C2-NH2 Agonist 96.09% Unkown
HY-126526 N3-PEG2-C2-NHS ester ≥98.0% Unkown
HY-140452 Azido-PEG2-C2-acid ≥97.0% Unkown
HY-N0602 Ginsenoside Rg2 Inhibitor 98.11% Unkown
HY-135804 NH2-PEG3-C2-Boc / Unkown
HY-W015088 Amino-PEG3-C2-Amine 99.32% Unkown
HY-42151 Mal-amido-PEG2-C2-acid 99.58% Unkown
HY-150795 SY-LB-35 ≥98.0% Unkown
HY-W092043 TLR4-IN-C34-C2-COOH Inhibitor ≥97.0% Unkown
HY-107452 SLF-amido-C2-COOH 99.82% Unkown
HY-112821 IBS008738 Activator 98.22% Unkown
HY-126528 N3-PEG3-C2-NHS ester 99.94% Unkown
HY-130485 Bromo-PEG2-C2-azide 98.10% Unkown
HY-125843 Pomalidomide-PEG1-C2-N3 99.91% Unkown
HY-101159 Mal-amido-PEG8-C2-acid 99.04% Unkown
HY-130549 Acid-PEG3-C2-Boc ≥97.0% Unkown
HY-D0187S L-Glutathione reduced-13C2,15N Inhibitor ≥95.0% Unkown
HY-W022240 NH2-PEG5-C2-NH-Boc ≥95.0% Unkown
HY-126502 Mal-C2-NHS ester 99.30% Unkown
HY-128846A Pomalidomide-C2-NH2 hydrochloride 99.46% Unkown
HY-22335 Amino-PEG4-C2-amine ≥98.0% Unkown
HY-112706 PF-06747711 Antagonist 99.86% Unkown
HY-112820 Chlorantraniliprole Activator 98.06% Unkown
HY-150644 S07-2010 Inhibitor 99.79% Unkown
HY-W017970 Boc-C2-NH2 99.63% Unkown
HY-137531 Pomalidomide-PEG1-C2-COOH 99.88% Unkown
HY-140009 Azido-PEG1-C2-acid ≥98.0% Unkown
HY-140480 Acid-PEG2-C2-Boc ≥98.0% Unkown
HY-147007 β-catenin-IN-3 Inhibitor 98.03% Unkown
HY-147025 (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine 99.06% Unkown
HY-148346A STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA Agonist 98.20% Unkown
HY-156406 PITCOIN4 Inhibitor 99.97% Unkown
HY-108307 Micronomicin sulfate Inhibitor ≥98.0% Unkown
HY-112452 SU11652 99.06% Unkown
HY-130436 Acid-C2-PEG4-C2-NHS ester ≥98.0% Unkown
HY-130483 Br-PEG3-C2-Boc ≥97.0% Unkown
HY-13836 ELQ-300 Inhibitor ≥98.0% Unkown
HY-130108 N3-PEG4-C2-Pfp ester ≥97.0% Unkown
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.76% Unkown
HY-135868 Mito-apocynin (C2) Inhibitor 98.38% Unkown
HY-139848 WS-898 Inhibitor 98.14% Unkown
HY-148896 (S,R,S)-AHPC-C2-PEG3-BCN ≥98.0% Unkown
HY-N1517 Ganoderic acid C2 99.30% Unkown
HY-W040168 Amino-PEG2-C2-acid ≥98.0% Unkown
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.04% Unkown
HY-128832 Nutlin-C1-amido-PEG4-C2-N3 97.32% Unkown
HY-124648 SMN-C2 98.85% Unkown
HY-126520 N3-C2-NHS ester ≥98.0% Unkown
HY-141364 Bromo-PEG1-C2-Boc 98.58% Unkown
HY-B0351S2 Taurine-13C2,15N Inducer 98.60% Unkown
HY-N0322S5 Cholesterol-13C2 Agonist 99.14% Unkown
HY-N7627 Regaloside C ≥99.0% Unkown
HY-W040165 Amino-PEG3-C2-acid ≥97.0% Unkown
HY-W580022 Pomalidomide-5'-PEG8-C2-COOH 98.21% Unkown
HY-N0091S3 Hypoxanthine-13C2,15N ≥91.0% Unkown
HY-124569 NAB-14 Antagonist / Unkown
HY-128716A Pomalidomide-PEG3-C2-NH2 TFA 99.0% Unkown
HY-130853 Thalidomide-NH-PEG2-C2-NH-Boc Inducer 98.37% Unkown
HY-128591 DIPQUO Activator 98.12% Unkown
HY-131880 Thalidomide-O-C2-acid Inducer 95.76% Unkown
HY-100246 CI-1044 Inhibitor 98.03% Unkown
HY-115384 Amino-PEG5-C2-acid ≥97.0% Unkown
HY-130315 Br-PEG4-C2-Boc ≥98.0% Unkown
HY-134512 Aminooxy-PEG3-C2-thiol ≥95.0% Unkown
HY-140127 Azide-C2-SS-C2-biotin 98.79% Unkown
HY-140543 N-DBCO-N-bis(PEG2-C2-acid) 96.65% Unkown
HY-141386 Bromoacetamido-PEG2-C2-NHS ester ≥95.0% Unkown
HY-23167 Acid-PEG4-C2-Boc / Unkown
HY-W010098S1 Terephthalic acid-13C2 98.58% Unkown
HY-W039168 Bromo-PEG3-C2-acid ≥97.0% Unkown
HY-Y0262S1 Oxalic acid-13C2 ≥99.0% Unkown
HY-Y0966S6 Glycine-13C2,15N ≥99.0% Unkown
HY-129703A Thalidomide-PEG2-C2-NH2 TFA Inducer 99.39% Unkown
HY-129703B Thalidomide-PEG2-C2-NH2 hydrochloride Inducer 99.61% Unkown
HY-107440A Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Inducer 98.29% Unkown
HY-112599B Pomalidomide-PEG4-C2-NH2 hydrochloride 99.11% Unkown
HY-136163 (S,R,S)-AHPC-C2-NH2 dihydrochloride 98.85% Unkown
HY-115450 ONO-0300302 Antagonist 99.43% Unkown
HY-119678 Fortunellin Activator 95.93% Unkown
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% Unkown
HY-130396 DBCO-PEG4-C2-acid 99.22% Unkown
HY-130414 Mal-amido-PEG4-acid 97.01% Unkown
HY-133597 4-Chlorocatechol 99.37% Unkown
HY-140585 N-DBCO-N-bis(PEG2-C2-NHS ester) ≥96.0% Unkown
HY-148080 Indole-C2-amide-C2-NH2 99.42% Unkown
HY-163084 HJ445A Inhibitor 98.31% Unkown
HY-B0228S10 (R)-3-Hydroxybutanoic acid-13C2 sodium ≥98.0% Unkown
HY-W025074 BML-278 Activator 98.49% Unkown
HY-107440 Thalidomide-O-amido-PEG3-C2-NH2 Inducer / Unkown
HY-112600A Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA Inducer 99.28% Unkown
HY-112617A Thalidomide-O-amido-PEG2-C2-NH2 TFA Inducer 99.52% Unkown
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / Unkown
HY-112599 Pomalidomide-PEG4-C2-NH2 95.11% Unkown
HY-122694A Thalidomide-O-amido-PEG-C2-NH2 hydrochloride Inducer 98.54% Unkown
HY-122710A Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Inducer ≥95.0% Unkown
HY-130521 Pomalidomide-amido-PEG3-C2-NH2 99.55% Unkown
HY-136162 Thalidomide-4-O-C2-NH2 hydrochloride Inducer 99.37% Unkown
HY-103154 SB228357 Antagonist 99.43% Unkown
HY-103611 Thalidomide-O-amido-PEG3-C2-NH2 TFA Inducer 99.55% Unkown
HY-108440 Shz-1 99.88% Unkown
HY-113071 Mevalonic acid ≥99.0% Unkown
HY-120773 Fmoc-PEG3-C2-NHS ester ≥95.0% Unkown
HY-121982 Cyclo(L-Phe-L-Val) Inhibitor 99.88% Unkown
HY-126507 Mal-amido-PEG1-C2-​NHS ester 99.90% Unkown
HY-126509 Mal-amido-PEG10-C2-​NHS ester 95.23% Unkown
HY-126512 Propargyl-C2-NHS ester 96.60% Unkown
HY-126881 Fmoc-PEG2-C2-NHS ester 98.89% Unkown
HY-128716 Pomalidomide-PEG3-C2-NH2 / Unkown
HY-128716B Pomalidomide-PEG3-C2-NH2 hydrochloride / Unkown
HY-128846 Pomalidomide-C2-NH2 / Unkown
HY-130095 NHPI-PEG2-C2-NHS ester 98.23% Unkown
HY-130097 Ald-Ph-amido-PEG4-C2-acid 99.09% Unkown
HY-130101 Ald-Ph-amido-PEG4-C2-NHS ester 98.75% Unkown
HY-130470 Chloroacetamido-PEG4-C2-Boc / Unkown
HY-130520 Bromoacetamido-PEG4-C2-Boc / Unkown
HY-130531 NH-bis(C2-PEG2-NH-Boc) ≥98.0% Unkown
HY-133070 Tos-PEG5-C2-Boc / Unkown
HY-135085 Thiol-C2-PEG2-OH ≥97.0% Unkown
HY-136395 Cartap Inducer / Unkown
HY-13677S1 6-Mercaptopurine-13C2,15N ≥96.0% Unkown
HY-13966S2 2-Deoxy-D-glucose-13C ≥98.0% Unkown
HY-140779 Azido-PEG6-C2-Boc 99.77% Unkown
HY-141362 Bromo-PEG2-C2-acid ≥97.0% Unkown
HY-141941S Triazole Lactic Acid-13C2, 15N3 / Unkown
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor ≥95.0% Unkown
HY-148346 STING agonist-20-Ala-amide-PEG2-C2-NH2 Agonist / Unkown
HY-148484 Pomalidomide-5'-PEG5-C2-COOH 98.80% Unkown
HY-154803 DLin-M-K-DMA ≥98.0% Unkown
HY-A0132S10 N-Acetyl-D-glucosamine-13C2,15N / Unkown
HY-B0166S3 L-Ascorbic acid-13C-2 ≥95.0% Unkown
HY-B0351S1 Taurine-13C2 Inducer ≥99.0% Unkown
HY-I0960S Uracil-13C2,15N2 ≥97.0% Unkown
HY-N0229S15 L-Alanine-13C2,15N ≥99.0% Unkown
HY-N0229S9 L-Alanine-13C2 ≥98.0% Unkown
HY-N0543S Allantoin-13C2,15N4 ≥99.0% Unkown
HY-N6980 Licorice glycoside C2 99.07% Unkown
HY-W013636S3 2-Ketoglutaric acid-13C ≥97.0% Unkown
HY-W021448S1 Glycocyamine-15N,13C2 ≥97.0% Unkown
HY-W040795 N2-Acetylguanine 99.69% Unkown
HY-Y0966S3 Glycine-13C2 99.10% Unkown
HY-103708 Nezukone 98.81% Unkown
HY-47373 Folate-PEG3-C2-acid 97.56% Unkown
HY-112600 Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Inducer / Unkown
HY-112617 Thalidomide-O-amido-PEG2-C2-NH2 Inducer / Unkown
HY-112617B Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride Inducer / Unkown
HY-122694 Thalidomide-O-amido-PEG-C2-NH2 Inducer / Unkown
HY-128353 ROR agonist-1 Antagonist / Unkown
HY-129703 Thalidomide-PEG2-C2-NH2 Inducer / Unkown
HY-131308 Thalidomide-NH-C2-PEG3-OH Inducer / Unkown
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride Inducer / Unkown
HY-141662 2',3'-cGAMP-C2-PPA Agonist / Unkown
HY-112608 CHMFL-PI3KD-317 Inhibitor 98.04% Unkown
HY-122710 Thalidomide-O-amido-PEG4-C2-NH2 / Unkown
HY-125883 Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc / Unkown
HY-100441S1 Treprostinil-13C2,d1 Inhibitor / Unkown
HY-103155 SB-221284 Antagonist / Unkown
HY-108379 Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid / Unkown
HY-108826 Iduronate sulfatase / Unkown
HY-110189S Pregnenolone monosulfate sodium-13C2,d2 / Unkown
HY-111095S3A D-(-)-Lactic acid-13C-2 sodium / Unkown
HY-111555 AmPEG6C2-Aur0131 Inhibitor / Unkown
HY-113263S1 17α-Hydroxypregnenolone-13C2,d2 / Unkown
HY-113295S Salicyluric acid-13C2,15N / Unkown
HY-113365S2 Cholestenone-13C2 / Unkown
HY-115945 Complex III-IN-1 Inhibitor / Unkown
HY-116877 C2 Ceramide (d14:1/2:0) / Unkown
HY-118574 UBP141 Antagonist / Unkown
HY-121507 Hydroxy-PEG2-C2-sulfonic acid / Unkown
HY-125887 Boc-NH-PEG2-C2-amido-C4-acid / Unkown
HY-126313 BnOH-NH-bis-(C2-S)-propane-O-isoprene ester / Unkown
HY-126381 Boc-N-PEG5-C2-NHS ester / Unkown
HY-126508 Mal-amido-PEG5-C2-​NHS ester / Unkown
HY-12650S Mirogabalin-13C2,d1 (Mixture of Diastereomers) / Unkown
HY-126510 MC-PEG2-C2-​NHS ester / Unkown
HY-126514 Propargyl-O-C1-amido-PEG2-C2-NHS ester / Unkown
HY-126515 Propargyl-O-C1-amido-PEG4-C2-NHS ester / Unkown
HY-126527 N3-PEG2-C2-PFP ester / Unkown
HY-126529 N3-PEG3-C2-PFP ester / Unkown
HY-126673 Mal-C2-Gly3-EDA / Unkown
HY-126677 Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA / Unkown
HY-126688 Mal-C2-Gly3-EDA-PNU-159682 / Unkown
HY-126949 Aminooxy-PEG3-azide / Unkown
HY-128741S2 D-Allose-13C-2 / Unkown
HY-128753S3 D-Lyxose-13C-2 / Unkown
HY-128793S trans-Stilbene-13C2 / Unkown
HY-129772 Phthalimide-PEG3-C2-OTs / Unkown
HY-130090 NHPI-PEG4-C2-Pfp ester / Unkown
HY-130091 NHPI-PEG4-C2-NHS ester / Unkown
HY-130092 NHPI-PEG3-C2-Pfp ester / Unkown
HY-130093 NHPI-PEG3-C2-NHS ester / Unkown
HY-130094 NHPI-PEG2-C2-Pfp ester / Unkown
HY-130096 Ald-Ph-amido-C2-nitrate / Unkown
HY-130102 Ald-Ph-amido-PEG3-C2-Pfp ester / Unkown
HY-130103 Ald-Ph-amido-PEG2-C2-Pfp ester / Unkown
HY-130104 Ald-Ph-amido-PEG2-C2-NHS ester / Unkown
HY-130105 Ald-Ph-amido-PEG1-C2-Pfp ester / Unkown
HY-130106 Ald-Ph-amido-PEG1-C2-NHS ester / Unkown
HY-130154 Ald-Ph-amido-PEG2-C2-acid / Unkown
HY-130164 Bromo-PEG3-C2-phosphonic acid / Unkown
HY-130174 Ald-Ph-amido-PEG3-C2-NH2 / Unkown
HY-130192 Cbz-NH-PEG8-C2-acid / Unkown
HY-130202 Ald-Ph-amido-PEG2-C2-Boc ≥97.0% Unkown
HY-130443 Cbz-NH-PEG6-C2-acid / Unkown
HY-130467 DNP-NH-PEG2-C2-acid / Unkown
HY-130488 Hydroxy-PEG2-C2-PFP ester / Unkown
HY-130489 Bromo-PEG5-C2-acid / Unkown
HY-130491 DNP-NH-PEG4-C2-Boc / Unkown
HY-130654 (S,R,S)-AHPC-C2-PEG4-N3 / Unkown
HY-130667 Ald-Ph-amido-C2-PEG3-azide / Unkown
HY-130669 Ald-Ph-amido-C2-PEG3-NH-Boc / Unkown
HY-130690 Propargyl-PEG1-SS-PEG1-C2-Boc ≥98.0% Unkown
HY-130712 NH2-C2-amido-C2-Boc / Unkown
HY-130713 Thalidomide-C2-amido-C2-COOH Inducer / Unkown
HY-130758 Ald-PEG1-C2-Boc / Unkown
HY-130931 Propargyl-NH-PEG3-C2-NHS ester / Unkown
HY-131866 (S,R,S)-CO-C2-acid / Unkown
HY-131992 N-Acetylpsychosine / Unkown
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc ≥95.0% Unkown
HY-133069 Tos-PEG2-C2-Boc / Unkown
HY-133071 Tos-PEG6-C2-Boc / Unkown
HY-133410 Mal-C2-cyclohexylcarboxyl-hydrazide TFA / Unkown
HY-133410A Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride 98.23% Unkown
HY-133509 DBCO-C2-SulfoNHS ester / Unkown
HY-133546 Ald-Ph-amido-PEG11-C2-NH2 / Unkown
HY-133583 Propargyl-O-C1-amido-PEG3-C2-NHS ester / Unkown
HY-13407S Gossypol-13C2 / Unkown
HY-13417S AICAR-13C2,15N / Unkown
HY-13458S1 Droxidopa-13C2,15N hydrochloride / Unkown
HY-134682 Fmoc-NH-PEG5-C2-NH2 / Unkown
HY-135931 m-PEG11-C2-NHS Ester / Unkown
HY-135959 DBCO-NH-PEG7-C2-NHS ester / Unkown
HY-136162A Thalidomide-4-O-C2-NH2 Inducer / Unkown
HY-136163A (S,R,S)-AHPC-C2-NH2 / Unkown
HY-13623CS (1R,3S,4R)-ent-Entecavir-13C2,15N / Unkown
HY-13623S1 Entecavir-13C2,15N / Unkown
HY-138316 THP-PEG10-C2-Boc / Unkown
HY-138349 THP-PEG6-C2-Boc / Unkown
HY-138358 Azido-PEG23-C2-azide / Unkown
HY-138362 Br-PEG6-C2-acid / Unkown
HY-138370 Boc-NH-PEG4-C2-Boc / Unkown
HY-138375 Mal-PEG5-C2-NH2 hydrochloride / Unkown
HY-138380 Mal-PEG4-C2-NH2 TFA / Unkown
HY-138381 Br-PEG6-C2-NHBoc / Unkown
HY-138384 Br-PEG9-C2-NHBoc / Unkown
HY-138390 NH2-PEG10-C2-dimethylamino / Unkown
HY-138397 Boc-NH-PEG15-C2-acid / Unkown
HY-138399 Boc-NH-PEG22-C2-NH2 / Unkown
HY-138406 Boc-NH-PEG8-C2-Br / Unkown
HY-138410 Boc-NH-PEG11-C2-acid / Unkown
HY-138425 Amino-PEG12-C2-azide / Unkown
HY-138432 Boc-NH-PEG26-C2-NH2 / Unkown
HY-138446 Amino-PEG4-C2-SH hydrochloride / Unkown
HY-138451 Amino-PEG7-C2-SH hydrochloride / Unkown
HY-138464 Br-Boc-C2-azido / Unkown
HY-138474 Boc-PEG1-PPG2-C2-azido / Unkown
HY-138485 Boc-PEG1-PPG2-C2-NH2 / Unkown
HY-138535 Azide-C2-Azide / Unkown
HY-138849 Thalidomide-NH-amido-C2-NH2 Inducer / Unkown
HY-138849A Thalidomide-NH-amido-C2-NH2 hydrochloride Inducer / Unkown
HY-138854 Thalidomide-NH-amido-PEG1-C2-NH2 Inducer / Unkown
HY-138854A Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride Inducer / Unkown
HY-138855 Thalidomide-NH-amido-PEG2-C2-NH2 Inducer / Unkown
HY-138855A Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride Inducer / Unkown
HY-138856 Thalidomide-NH-amido-PEG3-C2-NH2 Inducer / Unkown
HY-138856A Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride / Unkown
HY-138857 Thalidomide-NH-amido-PEG4-C2-NH2 / Unkown
HY-138857A Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride / Unkown
HY-139084 XL388-C2-NH2 / Unkown
HY-139085A XL388-C2-amide-PEG9-NH2 hydrochloride ≥95.0% Unkown
HY-139085B XL388-C2-amide-PEG9-NH2 TFA 95.97% Unkown
HY-140001 Amino-PEG3-C2-sulfonic acid / Unkown
HY-140011 Acid-C2-PEG3-NHS ester / Unkown
HY-140067 endo-BCN-PEG2-C2-NHS ester / Unkown
HY-140085 N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) / Unkown
HY-140101 Azido-C2-SS-PEG2-C2-acid / Unkown
HY-140164 Azido-PEG2-C2-sulfonic acid / Unkown
HY-140221 Azido-PEG1-C2-methylamine / Unkown
HY-140287 DBCO-C2-PEG4-amine / Unkown
HY-140294 DBCO-C2-PEG4-NH-Boc / Unkown
HY-140349 AZD-CO-C2-Ph-amido-Ph-azide / Unkown
HY-140406 Aminooxy-PEG3-C2-NH-Boc / Unkown
HY-140487 Cbz-NH-PEG2-C2-acid / Unkown
HY-140489 Cbz-NH-PEG5-C2-acid / Unkown
HY-140514 NH-bis(PEG2-C2-acid) / Unkown
HY-140550 NH-bis(C2-PEG1-azide) / Unkown
HY-140554 N-Boc-N-bis(C2-PEG1-azide) / Unkown
HY-140595 m-PEG3-S-PEG1-C2-Boc / Unkown
HY-140633 Ald-C2-PEG4-azide / Unkown
HY-140750 Benzyloxy carbonyl-PEG3-C2-Boc / Unkown
HY-140776 Azido-PEG2-C2-Boc / Unkown
HY-140819 Bromo-PEG1-C2-azide / Unkown
HY-140834 Boc-N-Amido-PEG2-C2-azide / Unkown
HY-141116 Boc-N-PEG1-C2-NHS ester / Unkown
HY-141122 Boc-PEG4-C2-NHS ester / Unkown
HY-141245 Hydroxy-PEG4-C2-nitrile / Unkown
HY-141323 C2-Bis-phosphoramidic acid diethyl ester / Unkown
HY-141388 Bromoacetamido-PEG3-C2-Boc / Unkown
HY-141663 2',3'-cGAMP-C2-SH / Unkown
HY-141798 OICR-9429-N-C2-NH2 / Unkown
HY-141878 di-Ellipticine-RIBOTAC Modulator / Unkown
HY-143784S C14 Benzalkonium-1 acid-13C2,d11 chloride / Unkown
HY-143943S Felodipine 3,5-dimethyl ester-13C2,d6 / Unkown
HY-144128 hGGPPS-IN-1 / Unkown
HY-144129 hGGPPS-IN-2 / Unkown
HY-144130 hGGPPS-IN-3 / Unkown
HY-144150S Pelubiprofen impurity 2-13C2,d6 / Unkown
HY-144153S S-(1,2-Dichlorovinyl)glutathione-13C2,15N / Unkown
HY-144427S Vitamin E-13C2,d6 / Unkown
HY-145247 Biotin-PEG7-C2-S-Vidarabine Inhibitor / Unkown
HY-145248 Biotin-PEG7-C2-NH-Vidarabine-S-CH3 Inhibitor / Unkown
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / Unkown
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / Unkown
HY-14608S10 L-Glutamic acid-13C2 / Unkown
HY-146194 NHEJ inhibitor-1 Activator / Unkown
HY-146196 Anticandidal agent-1 Inhibitor / Unkown
HY-146573 AKR1C3-IN-6 Inhibitor / Unkown
HY-146994S2 L-Idose-13C-2 / Unkown
HY-147716 CDK8-IN-6 Inhibitor / Unkown
HY-147717 CDK8-IN-7 Inhibitor / Unkown
HY-147835 Antibacterial agent 109 Inhibitor / Unkown
HY-148136 sEH inhibitor-7 Inhibitor 99.71% Unkown
HY-148171 L-2'-Fd4C Inhibitor / Unkown
HY-148472A C2-Amide-C4-NH2 / Unkown
HY-149255 PTP1B/AKR1B1-IN-2 Inhibitor / Unkown
HY-150525S Acetyl-1,2 Coenzyme A-13c2 Lithium / Unkown
HY-150623 SARS-CoV-2 nsp13-IN-2 Inhibitor / Unkown
HY-150631S Glutathione-glycine-13C2,15N trifluoroacetate / Unkown
HY-150915S Uracil 4,5-13c2 / Unkown
HY-152297 (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol / Unkown
HY-152305 (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol / Unkown
HY-152463 4′-C-2-Propen-1-yluridine / Unkown
HY-153042 Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride / Unkown
HY-153371 50-C2-C9-4tail / Unkown
HY-153538 AP-C2 Inhibitor / Unkown
HY-155705 BMP agonist 1 / Unkown
HY-156304 Coumarin-C2-TCO / Unkown
HY-156305 Coumarin-C2-exo-BCN / Unkown
HY-156882 Biotin-PEG3-amide-C2-CO-Halofuginone / Unkown
HY-157386S 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 / Unkown
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / Unkown
HY-157749 Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 Inducer / Unkown
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / Unkown
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / Unkown
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / Unkown
HY-160449 p53 Activator 10 Activator / Unkown
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / Unkown
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / Unkown
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / Unkown
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / Unkown
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / Unkown
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / Unkown
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / Unkown
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / Unkown
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / Unkown
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / Unkown
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / Unkown
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / Unkown
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 / Unkown
HY-161394 SPRT / Unkown
HY-162046 Anticancer agent 178 Inducer / Unkown
HY-162081 BTK-IN-32 Inhibitor / Unkown
HY-16271S Kevetrin hydrochloride-13C2,15N3 p53 Activator / Unkown
HY-163078 C2-Gal-Dox / Unkown
HY-163224 (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / Unkown
HY-163228 PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / Unkown
HY-16973S Fluralaner-13C2,15N,d3 Inhibitor / Unkown
HY-17530S Aldicarb sulfone-13C2,d3 / Unkown
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / Unkown
HY-40171S NH2-C2-NH-Boc-d4 / Unkown
HY-48394A Bis-S-C2-N(N-Me)-C2-OH dihydrochloride / Unkown
HY-66005S4 Acetaminophen-13C2,15N / Unkown
HY-77956S2 Thyminose-13C-2 / Unkown
HY-79369S1 Succinic anhydride-13C2 / Unkown
HY-A0084S1 Procainamide-13C2 hydrochloride / Unkown
HY-A0132S3 N-Acetyl-D-glucosamine-13C-2 / Unkown
HY-B0141S5 Estradiol-13C2 Agonist / Unkown
HY-B0149S3 Tranexamic acid-13C2,15N / Unkown
HY-B0151S1 Pregnenolone-13C2,d2 / Unkown
HY-B0216S2 Ethynyl Estradiol-13C2 Agonist / Unkown
HY-B0220S3 Erythromycin-13C2 Inhibitor / Unkown
HY-B0234S3 Estrone-13C2 Agonist / Unkown
HY-B0318S Metronidazole-13C2,15N2 99.30% Unkown
HY-B0389S12 D-Glucose-13C-2 / Unkown
HY-B0389S14 D-Glucose-13C2 / Unkown
HY-B0389S15 D-Glucose-13C2-4 ≥98.0% Unkown
HY-B0389S22 D-Glucose-13C2,d2 / Unkown
HY-B0400S3 D-Sorbitol-13C-2 / Unkown
HY-B0495S3 Lamotrigine-13C2,15N / Unkown
HY-B0508S1 Ornidazole-13C2,15N2 Inhibitor / Unkown
HY-B0579S3 Cyclosporin A-13C2,d4 Inhibitor / Unkown
HY-B0782S1 Acetazolamide-13C2,d3 / Unkown
HY-B0863S3 Glyphosate-13C2,15N / Unkown
HY-B1118S1 Secnidazole-13C2, 15N2 Inhibitor / Unkown
HY-B1337S5 Choline-13C2 chloride / Unkown
HY-B1449S3 Uridine-13C-2 / Unkown
HY-B1640S Ethacrynic acid-13C2,d5 / Unkown
HY-B1659S4 Glycerol-13C2 / Unkown
HY-B1842S Fluroxypyr-13C2 / Unkown
HY-B1912S1 Amidosulfuron-13C2,d6 / Unkown
HY-D1546 Biotin-C2-maleimide / Unkown
HY-D1551 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-I0400S2 N-Acetylneuraminic acid-13C-2 / Unkown
HY-I0626S Cytosine-2,4-13C2-1,3-15N2 / Unkown
HY-I0736S Isonicotinic acid-d4 / Unkown
HY-N0059S2 D-arabinose-13C-2 / Unkown
HY-N0210S1 D-Galactose-13C-2 / Unkown
HY-N0379S7 D-Mannose-13C-2 / Unkown
HY-N0390S10 L-Glutamine-1,2-13C2 / Unkown
HY-N0394S4 L-Cystine-3,3'-13C2 / Unkown
HY-N0420S3 Butanedioic acid-13C2 / Unkown
HY-N0420S4 Succinic acid-13C2 / Unkown
HY-N0437S3 Progesterone-13C2 Agonist / Unkown
HY-N0455AS5 L-Arginine-1,2-13C2 hydrochloride Activator / Unkown
HY-N0473S6 L-Tyrosine-3,5-13C2 99.43% Unkown
HY-N0545S Taurocholic acid-13C2,15N sodium Agonist / Unkown
HY-N0602R Ginsenoside Rg2 (Standard) Inhibitor / Unkown
HY-N0666S6 L-Aspartic acid-1,4-13C2 ≥99.0% Unkown
HY-N0666S7 L-Aspartic acid-1,4-13C2,15N / Unkown
HY-N0830S10 Palmitic acid-13C2 Activator / Unkown
HY-N10579 Chrexanthomycin C Modulator / Unkown
HY-N10595 Ladanetin-6-O-β-(6′′-O-acetyl)glucoside / Unkown
HY-N10642 Pedaliin 6''-acetate / Unkown
HY-N10869 Pseudolaric acid C2-O-β-D-glucoside / Unkown
HY-N1150S4 Thymidine-13C-2 / Unkown
HY-N12447 C-2′-Decoumaroylaloeresin G / Unkown
HY-N1420AS2 Rhamnose-13C-2 monohydrate / Unkown
HY-N1480S2 (-)-Fucose-13C-2 / Unkown
HY-N3205 Neochamaejasmin B / Unkown
HY-N3231 Murraol Inhibitor / Unkown
HY-N3671 Cycloshizukaol A / Unkown
HY-N3686S2 D-Arabitol-13C-2 / Unkown
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.94% Unkown
HY-N6625S Chlorothalonil-13C2 Inhibitor / Unkown
HY-N6910 Pseudolaric Acid C2 99.17% Unkown
HY-N7092S3 D-Fructose-13C2 ≥98.0% Unkown
HY-N7398S 2-Pentylfuran-13C2 / Unkown
HY-P2741 Maltose phosphorylase / Unkown
HY-P5881 PKCα (C2-4) inhibitor peptide Inhibitor / Unkown
HY-R00539 hsa-miR-30c-2-3p mimic / Unkown
HY-R00539A hsa-miR-30c-2-3p agomir / Unkown
HY-RI00539 hsa-miR-30c-2-3p inhibitor / Unkown
HY-RI00539A hsa-miR-30c-2-3p antagomir / Unkown
HY-RS00535 AKR1C2 Human Pre-designed siRNA Set A / Unkown
HY-RS01199 ATP2C2 Human Pre-designed siRNA Set A / Unkown
HY-RS01227 ATP6V1C2 Human Pre-designed siRNA Set A / Unkown
HY-RS01738 C2 Human Pre-designed siRNA Set A / Unkown
HY-RS01740 C2CD3 Human Pre-designed siRNA Set A / Unkown
HY-RS01741 C2CD5 Human Pre-designed siRNA Set A / Unkown
HY-RS01742 C2orf69 Human Pre-designed siRNA Set A / Unkown
HY-RS05907 GTF3C2 Human Pre-designed siRNA Set A / Unkown
HY-RS05968 H3C2 Human Pre-designed siRNA Set A / Unkown
HY-RS05975 H4C2 Human Pre-designed siRNA Set A / Unkown
HY-RS09537 NR2C2 Human Pre-designed siRNA Set A / Unkown
HY-RS09538 NR2C2AP Human Pre-designed siRNA Set A / Unkown
HY-RS09547 NR3C2 Human Pre-designed siRNA Set A / Unkown
HY-RS09548 Nr3c2 Mouse Pre-designed siRNA Set A / Unkown
HY-RS09549 Nr3c2 Rat Pre-designed siRNA Set A / Unkown
HY-RS09609 NT5C2 Human Pre-designed siRNA Set A / Unkown
HY-RS10511 PIK3C2A Human Pre-designed siRNA Set A / Unkown
HY-RS10512 Pik3c2a Mouse Pre-designed siRNA Set A / Unkown
HY-RS10513 Pik3c2a Rat Pre-designed siRNA Set A / Unkown
HY-RS10514 PIK3C2B Human Pre-designed siRNA Set A / Unkown
HY-RS10515 Pik3c2b Mouse Pre-designed siRNA Set A / Unkown
HY-RS10516 Pik3c2b Rat Pre-designed siRNA Set A / Unkown
HY-RS10517 PIK3C2G Human Pre-designed siRNA Set A / Unkown
HY-RS10518 Pik3c2g Mouse Pre-designed siRNA Set A / Unkown
HY-RS10519 Pik3c2g Rat Pre-designed siRNA Set A / Unkown
HY-RS14017 SULT1C2 Human Pre-designed siRNA Set A / Unkown
HY-W006057AS Sodium 3-methyl-2-oxobutanoate-13C2,d1 / Unkown
HY-W006057AS17 3-Methyl-2-oxobutanoic acid-13c2 / Unkown
HY-W006057AS3 Sodium 3-methyl-2-oxobutanoate-13C2,d4 / Unkown
HY-W008807S Phosphoenolpyruvic acid potassium-13C2 / Unkown
HY-W010042S2 L-Glucose-13C-2 / Unkown
HY-W010452S2 3-Hydroxybutyric acid-13C2 sodium / Unkown
HY-W012684S Ethane-1,2-diamine dihydrochloride-13C2 / Unkown
HY-W012864S2 (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 / Unkown
HY-W013061S5 Propane-1,2,3-triyl tripalmitate-13C2 / Unkown
HY-W013495S Porphobilinogen-13C2 / Unkown
HY-W015410S Disodium succinate-13C2 / Unkown
HY-W015883AS Fumaric acid2,3-13C2 disodium / Unkown
HY-W015883S2 Fumaric acid-13C2,d2 / Unkown
HY-W015913S4 2-Oxopropanoate-13c2 sodium / Unkown
HY-W017018S1 L-Ornithine-1,2-13C2 hydrochloride / Unkown
HY-W017072S 1-Dodecene-1,2-13C2 / Unkown
HY-W017387S1 Alpha-ketoisocaproic acid-13C2 sodium / Unkown
HY-W017522S6 Adipic acid-13C2 / Unkown
HY-W018772S16 D-Ribose-1,2-13C2 / Unkown
HY-W018772S3 D-Ribose-13C-2 / Unkown
HY-W019796 Cbz-NH-PEG4-C2-acid / Unkown
HY-W035903S 2-Aminoethan-1-ol-13c2 hydrochloride / Unkown
HY-W040028 Cartap hydrochloride Inducer / Unkown
HY-W040240S2 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 / Unkown
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / Unkown
HY-W048482S rU Phosphoramidite-13C2,d1 / Unkown
HY-W096111A Trt-PEG4-C2-acid hydrate / Unkown
HY-W096132 Dimethylamino-PEG2-C2-NH2 / Unkown
HY-W099580S Hexadecane-1,2-13C2 / Unkown
HY-W127841 Citric acid-2,4-13C2 / Unkown
HY-W338294S1 2'-Deoxycytidine-13C-2 monohydrate / Unkown
HY-W584529 VH032-C2-NH-Boc / Unkown
HY-W584532 VH032-O-C2-NH-Boc / Unkown
HY-W778203 Glycolic acid-13C2 / Unkown
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% Unkown
HY-Y0219S 1,2,4-Triazole-13C2,15N3 / Unkown
HY-Y0262BS Oxalic Acid-13C2 disodium / Unkown
HY-Y0338S1 Ethylene glycol-13C2 / Unkown
HY-Y0383S2 Dimethyl terephthalate-13C2-1 / Unkown
HY-Y0418S2 Dulcite-13C-2 / Unkown
HY-Y0674S Dicyandiamide-13C2,15N2 / Unkown
HY-Y0677S Carbethoxymethyldiethyl phosphonate-C13 / Unkown
HY-Y0781S3 Pyruvic acid-13C-2 sodium / Unkown
HY-Y0966S11 Glycine-13C2,15N,d2 / Unkown
HY-Y0989S2 Acetophenone-1,2-13C2 / Unkown
HY-Y1088S Hydrocinnamic acid-2,3-13C2 / Unkown
HY-Y1250S5 Fmoc-Gly-OH-13C2 / Unkown
HY-Y1250S6 Fmoc-Gly-OH-13C2,15N Inhibitor / Unkown
HY-100043S 2-Ethyl-3,5-dimethylpyrazine-13C2 / Unkown
HY-116700 Hinnuliquinone Inhibitor / Unkown
HY-118560S Tricyclodecenyl acetate-13C2 / Unkown
HY-132212 LH1307 Inhibitor / Unkown
HY-132223 LH1306 Inhibitor / Unkown
HY-132644S1 3-Demethyl Thiocolchicine--13C2,d6 / Unkown
HY-133358 Cbz-NH-PEG12-C2-acid / Unkown
HY-138965A Pomalidomide-5-C2-NH2 hydrochloride / Unkown
HY-140157 N-Me-N-bis(PEG4-C2-Boc) / Unkown
HY-14164S1 Zileuton-13C2,15N Inhibitor / Unkown
HY-144348S N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N / Unkown
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / Unkown
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride 98.01% Unkown
HY-156326S (3E,5E)-Octadien-2-one-13C2 / Unkown
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / Unkown
HY-160069 Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH / Unkown
HY-160235 Pomalidomide-C2-amide-C5-azide / Unkown
HY-17416AS1 Guanfacine-15N3,13C2 Agonist / Unkown
HY-76204S1 Glycine ethyl ester-13C2 hydrochloride / Unkown
HY-90009AS Tadalafil-13C2,d3 / Unkown
HY-B0124S1 Zonisamide-13C2,15N / Unkown
HY-B0495S6 Lamotrigine-13C2,15N2,d3 / Unkown
HY-B0523S Anagrelide-13C2,15N,d2 / Unkown
HY-B0712S1 Ceftriaxone-13C2,d3 triethylammonium salt Inhibitor / Unkown
HY-B1290S3 2-Phenylethanol-13C2 Inhibitor / Unkown
HY-N0091S4 Hypoxanthine-13C2,15N-1 / Unkown
HY-N12156 Ajugasterone C 2-acetate / Unkown
HY-N12297 Ciwujianoside C2 / Unkown
HY-N7093S Furaneol-13C2 / Unkown
HY-N7125S Cinnamyl acetate-13C2 / Unkown
HY-N7521 Procyanidin C2 / Unkown
HY-N9484S Menthofuran-13C2 / Unkown
HY-W001942S2 DL-2-Methylbutyric acid-13C2 / Unkown
HY-W010392S1 Ethyl 2-methylbutanoate-13C2 / Unkown
HY-W010489S1 2-Phenylacetaldehyde-13C2 / Unkown
HY-W012980S4 Isovaleric acid-13C2 / Unkown
HY-W012998S1 2,3-Pentanedione-13C2 / Unkown
HY-W015307S 4-Ethyloctanoic acid-13C2 / Unkown
HY-W015604S 2,3-Diethyl-5-methylpyrazine-13C2 / Unkown
HY-W020678S 2-Methylbutanal-13C2 / Unkown
HY-W102356S1 Phenethyl acetate-13C2 / Unkown
HY-W127515S trans-2,cis-6-Nonadienal-13C2 / Unkown
HY-W343292S 2-Methylbutyl acetate-13C2 / Unkown
HY-Y0045S 2-Acetylthiazole-13C2 / Unkown

Orthologs Information

Species Symbol Source ID
Felis catus C2 VGNC VGNC:102387
Bos taurus C2 VGNC VGNC:53959
Mus musculus C2 MGD MGI:88226
Canis familiaris C2 VGNC VGNC:103663
Rattus norvegicus C2 RGD RGD:2231
Macaca fascicularis C2 NCBI
Macaca mulatta C2 NCBI
Others C2 NCBI